Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Psoriasis”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03331835
What this trial is testing

A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 210
Post-approval studies (Phase 4)Study completedNCT00581555
What this trial is testing

Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy

Who this might be right for
Psoriasis
Pfizer 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06143878
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 774
Post-approval studies (Phase 4)Study completedNCT02752776
What this trial is testing

Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 1,660
Not applicableStudy completedNCT00893126
What this trial is testing

Premature Coronary Artery Disease (CAD) in Severe Psoriasis

Who this might be right for
PsoriasisCoronary Artery Disease
University of Michigan 46
Post-approval studies (Phase 4)Study completedNCT04271540
What this trial is testing

MIcrovascular dysfuNction In Moderate-severe Psoriasis

Who this might be right for
PsoriasisCardiovascular Disease
Marcelo F. Di Carli, MD, FACC 36
Early research (Phase 1)UnknownNCT03424629
What this trial is testing

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

Who this might be right for
Moderate and Severe Plaque Psoriasis
Tianjin Ever Union Biotechnology Co., Ltd. 57
Testing effectiveness (Phase 2)Looking for participantsNCT07449702
What this trial is testing

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 240
Large-scale testing (Phase 3)Study completedNCT02718898
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis

Who this might be right for
Genital PsoriasisPsoriasis
Eli Lilly and Company 149
Not applicableUnknownNCT04912401
What this trial is testing

The Efficacy and Safety of Etanercept （Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis

Who this might be right for
PsoriasisEtanercept
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Not applicableStudy completedNCT05803187
What this trial is testing

Clinical Study of Stage IV Psoriasis in Children With Geleli

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 80
Post-approval studies (Phase 4)Study completedNCT04571567
What this trial is testing

Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Saakshi Khattri 20
Testing effectiveness (Phase 2)Study completedNCT04999839
What this trial is testing

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Takeda 259
Testing effectiveness (Phase 2)Study completedNCT04718896
What this trial is testing

Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
UCB Biopharma SRL 41
Not applicableWithdrawnNCT01758705
What this trial is testing

Post Marketing Observational Study on Venezuelan Patients With Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbbVie (prior sponsor, Abbott)
Testing effectiveness (Phase 2)Study completedNCT05003531
What this trial is testing

Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Innovent Biologics (Suzhou) Co. Ltd. 250
Large-scale testing (Phase 3)Study completedNCT02474069
What this trial is testing

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 772
Large-scale testing (Phase 3)Study completedNCT00115076
What this trial is testing

Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Rockefeller University 31
Large-scale testing (Phase 3)Study completedNCT00235820
What this trial is testing

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 271
Large-scale testing (Phase 3)Study completedNCT00400725
What this trial is testing

Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
Galderma R&D 288
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation